Corporate Governance11 Nov 2026, 05:50 pm
Samsrita Labs: No Deviation in Preferential Issue Fund Use for Q2 FY27
AI Summary
Samsrita Labs Limited has reported no deviation or variation in the utilization of funds raised through a preferential issue for the quarter ended September 30, 2026. The total amount raised was ₹339.10 Lakhs (₹3.39 Crore) on July 18, 2025. The funds were allocated to working capital requirements (₹52.10 Lakhs), investment in new projects/opportunities/ventures (₹132.46 Lakhs), repayment of unsecured loans in part to the promoter director (₹88.31 Lakhs), and general corporate purposes (₹66.23 Lakhs). The Audit Committee reviewed and confirmed the utilization, finding no discrepancies.
Key Highlights
- No deviation reported in the use of preferential issue funds for Q2 FY27.
- Total funds raised were ₹339.10 Lakhs (₹3.39 Crore) via preferential issue.
- Funds were allocated across working capital, new investments, loan repayment, and general corporate purposes.
- Audit Committee reviewed and approved the fund utilization statement.
Price Impact
More from SAMSRITA